Gene · 7832
Papers2,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fertility under fire: how chemotherapy harms the ovaries and the science fighting back? | J Ovarian Res | 2026 | 41501826 | PubTator, text mining | PubMed |
| MLN4924 promotes the transcriptional activation of BTG2 via the ROS/EGR1-mediated signaling axis to suppress acute myeloid leukemia progression. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 41496600 | PubTator, text mining | PubMed |
| Development and validation of a heme metabolism-related genes signature for diagnosis and immunological characterization of lupus nephritis. | Clin Chim Acta | 2026 | 40976321 | PubTator, text mining | PubMed |
| Exofection by exosomes: A transient functional cargo transfer. | Extracell Vesicle | 2025 | 42344842 | PubTator, text mining | PubMed |
| Integrative bulk and single-cell transcriptome analyses reveal integrated stress response-related biomarkers in periodontitis with experimental validation. | Front Immunol | 2025 | 41459503 | PubTator, text mining | PubMed |
| Targeting NADPH oxidase 2 suppresses the growth of esophageal squamous cell carcinoma by regulating BTG2 pathway. | Discov Oncol | 2025 | 41441930 | PubTator, text mining | PubMed |
| SIDISH integrates single-cell and bulk transcriptomics to identify high-risk cells and guide precision therapeutics through in silico perturbation. | Nat Commun | 2025 | 41372157 | PubTator, text mining | PubMed |
| Long non-coding RNA Nkx2-2as/BTG2 axis attenuates breast cancer progression by targeting Wnt/β-catenin signaling. | Med Oncol | 2025 | 41273605 | PubTator, text mining | PubMed |
| A comparison of computational methods for expression forecasting. | Genome Biol | 2025 | 41250104 | PubTator, text mining | PubMed |
| Decoding the hypoxia-exosome-immune triad in OSA: PRCP/UCHL1/BTG2-driven metabolic dysregulation revealed by interpretable machine learning. | Front Immunol | 2025 | 41221287 | PubTator, text mining | PubMed |
| KIAA1429 in non-small cell lung cancer: bridging m6A epigenetics to therapeutic innovation. | Front Surg | 2025 | 41190085 | PubTator, text mining | PubMed |
| Unveiling miRNA biomarkers for hypertrophic cardiomyopathy through integrated bioinformatics and machine learning analysis. | Acta Cardiol | 2025 | 41133914 | PubTator, text mining | PubMed |
| Single-cell RNA-seq combined with bulk RNA-seq analysis identifies necroptosis-related genes as therapeutic targets for periodontitis. | BMC Med Genomics | 2025 | 41088263 | PubTator, text mining | PubMed |
| Genes with altered expression by 5-Aza treatment in myeloid leukemia cells through methylation in intron 1. | Leuk Res | 2025 | 41016225 | PubTator, text mining | PubMed |
| Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer. | Discov Oncol | 2025 | 41003822 | PubTator, text mining | PubMed |
| Identification of type 2 diabetes- and obesity-associated human β-cells using deep transfer learning. | Elife | 2025 | 40982369 | PubTator, text mining | PubMed |
| Lymphoma driver mutations at the root of somatic evolution of nerve-damaging autoantibodies in myelin associated glycoprotein neuropathy. | J Autoimmun | 2025 | 40915157 | PubTator, text mining | PubMed |
| YY1 lactylation promotes fibroblast senescence by targeting the PU.1-BTG2 axis to promote oral submucous fibrosis. | Chem Biol Interact | 2025 | 40889692 | PubTator, text mining | PubMed |
| Sodium-glucose cotransporter 2 inhibitors alleviate renal fibrosis in diabetic kidney disease by inhibiting Hmgcs2 and Btg2 in proximal tubular cells. | J Transl Med | 2025 | 40855324 | PubTator, text mining | PubMed |
| Second-order allosteric control as a mechanism for compensatory mutations in B-cell translocation gene 2. | Protein Sci | 2025 | 40852883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7832/papers?page=3